traumatic brain injury News
-
WVXU: Local Company’s Brain Scanner Can Quickly Detect Damage, Which Could Help The Military And Beyond
More than 400,000 military personnel have suffered at least one traumatic brain injury in the last two decades. Long-term consequences for patients may have been better if doctors could more quickly have diagnosed the situation and treated it. Now there appears to be a solution and it involves the Norwood company Sense Neuro Diagnostics. ...
-
CincyInno: Cincinnati startup lands multimillion dollar military contract
Sense Neuro Diagnostics, founded in 2014 by four University of Cincinnati physicians, said the $2.43 million, 18-month award from the U.S. Department of Defense will accelerate development of a new rapid, noninvasive brain scanner that can detect and continuously monitor traumatic brain injury in a battlefield or field environment. TBI, for short, is a signature wound of recent wars. There have ...
-
NFL & GE Announce Six Final Winners of $10 Million Head Health Challenge
Innovations are advancing the understanding and diagnosis of mild traumatic brain injury Breakthrough ideas include: point-of-care blood test to rapidly detect the presence of mild and moderate brain trauma; biomarkers that indicate how the brain reacts following a traumatic brain injury (TBI) and a method to identify which brain areas become disconnected after injury GE (NYSE: GE) and the ...
-
BrainScope Completes Agreement with 18,000 Member Yankee Alliance
BrainScope today announced a new system-wide agreement with Yankee Alliance to make BrainScope’s innovative point-of-care neuro-technology system available to the 18,000 members, including over 5000 outpatient facilities and senior centers, in Yankee Alliance. BrainScope is the only FDA cleared medical device that aids in the objective triage of head injured patients for suspected mild ...
-
BrainScope Receives $4.5 Million Department of Defense Contract to Add Ocular Assessment to Future Concussion Products
BrainScope today announced that it has been awarded a research contract by the United States Department of Defense (DOD) valued at $4.5 million to create and integrate ocular capabilities into its handheld, multi-parameter mild Traumatic Brain Injury (mTBI) and concussion products. BrainScope’s initial product in the market, BrainScope One, is the first FDA-cleared medical device to offer ...
-
TIKOMED’S ILB® restores brain energy metabolism following severe traumatic brain injury in the rat demonstrated in data published by the journal Antioxidants
A new study on TIKOMED’s lead drug candidate, ILB®, addressing one of the underlying causes of neurodegeneration in acute and chronic diseases was published in Antioxidants today. The data from the rodent model studying severe traumatic brain injury (sTBI), showed that a single post-injury injection of ILB® has beneficial effects on the metabolic damages caused by sTBI. “This ...
By TIKOMED AB
-
Ride 2 Recovery and GE Veterans Network launch new program to help veterans with traumatic brain injuries, post traumatic stress and depression
The GE Veterans Network (GEVN) and Ride 2 Recovery (R2R) have kicked off a new program that is designed to generate awareness and support for America’s healing heroes who have returned from military service with Traumatic Brain Injuries (TBI), Post Traumatic Stress (PTS), depression and other wounds. “This is an exciting partnership that will combine the passion, commitment, and ...
-
Newronika Raises an 8.4M EUR Series-A Round
Newronika, a spin-off of world-class neurological research centers Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by French venture capital fund Omnes together with existing investors Innogest Capital and Indaco Venture Partners SGR ("Indaco SGR") on behalf of Indaco Ventures I and Atlante Ventures funds. F3F and an undisclosed ...
-
Sense announces strategic collaboration with healthcare catalyst Inflect Health
Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, today announced a strategic collaboration with Inflect Health, the new nationwide, multispecialty investment and innovation hub formed by Vituity. As part of this new relationship, Inflect Health will provide Sense access to its robust network of frontline physicians and ...
-
LOK Corporation and Sense Neuro Diagnostics Announce Commercial Partnership Focused on International Market
(August 17, 2021—Montreal, Canada and Cincinnati, Ohio) LOK Corporation, a manufacturing agent that helps companies develop and manage their international distribution network and Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients today announced a commercial partnership to bring innovative brain scanners being developed ...
-
BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment
BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it has received FDA clearance to include additional language in its product’s Indications for Use (IFU), adding key terminology related to “multi-modal, multi-parameter assessment" of “concussion" and “mild Traumatic Brain ...
-
UT Health San Antonio offers summer program for people with aphasia
The news of actor Bruce Willis’ aphasia diagnosis is drawing attention to a condition that is fairly common but not well understood by the general public. Aphasia is a condition that affects a person’s ability to communicate. People with aphasia can have difficulty understanding or expressing themselves verbally, in writing — or both. “Most people haven’t heard of ...
By BioMedSA
-
BrainScope and Aon Secure IP-based Deal Funding Full Expansion of Commercial Activities and Pursuit of New Indications for BrainScope’s Next-Gen Medical Device Platform
Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement. The funding arrangement provides BrainScope with up to $35 million in capital to fund the full expansion of its commercial activities as well as to develop new clinical applications on its ...
-
BrainScope Honors Veterans Day and Supports U.S. Army Deployment of Traumatic Brain Injury (TBI) and Concussion Assessment Devices
BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it has fulfilled orders for over 170 BrainScope One handheld devices and over 7,500 individual patient headsets to U.S. Army bases across the world. U.S. Army medics and clinicians continue to receive the training necessary to support the assessment of ...
-
BrainScope Wins BioHealth Capital Region 5th Annual Crab Trap Competition
BrainScope, a medical neurotechnology company that is a pioneer in the use of A.I. and machine learning in the creation of biomarkers of brain injuries and disease was selected from five finalists as the company with the most commercial potential at the 5th Annual BioHealth Capital Region Crab Trap Competition. The Bethesda, Maryland based company is helping hospital Emergency Departments (EDs) ...
-
BrainScope Announces Publication Describing Proprietary Concussion Biomarker to Assess Potential Severity and Predict Prolonged Recovery
BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that researchers have published preliminary results related to a multi-modal concussion assessment capability for potential severity and likelihood of prolonged recovery from concussions. Published in the peer-reviewed journal Computers in Biology and ...
-
Over 30% Reduction in Unnecessary Head CT Scans When Integrating FDA-Cleared BrainScope One
BrainScope announced today the publication of a study conducted by physicians at Washington University Barnes Jewish Medical Center in St. Louis in the peer-reviewed journal The American Journal of Emergency Medicine entitled “Reduction in unnecessary CT scans head-injury in the emergency department using an FDA cleared device." The study demonstrated that the FDA-cleared BrainScope One ...
-
BrainScope Completes Large-Scale Clinical Studies of Concussion in Universities, High Schools and Concussion Clinics
BrainScope®, a medical neuro-technology company focused on concussion and mild traumatic brain injury (mTBI) assessment, announced today that it had concluded both algorithm development and clinical validation studies in adolescent and young adult populations using its objective, EEG-based technology. The purpose of the studies was to create and validate an objective, personalized capability ...
-
BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product
BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for “Best Medical Technology" product. Its flagship BrainScope One product is a multi-modal, comprehensive, handheld capability to help clinicians objectively and rapidly assess and triage head injured patients directly at the point of care. BrainScope’s innovative technology ...
-
TecTraum’s pro2cool Receives FDA Designation as a Breakthrough Device for the Treatment of Concussions
TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, today announced that the U.S. Food and Drug Administration (FDA) has designated its flagship technology, pro2cool, as a Breakthrough Device. The pro2cool System is a novel, non-invasive hypothermic therapy device designed to reduce the severity of concussion symptoms and allow patients to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you